Roadmap for elimination of gastric cancer in Korea
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Most gastric cancers are caused by infection with the common human bacterialpathogen, Helicobacter pylori. It is now accepted that gastric cancer can be preventedand virtually eliminated by H. pylori eradication and this knowledge wasresponsible for country-wide H. pylori eradication combined with secondary cancerprevention for those with residual risk that was introduced in Japan in 2013. Korea is a high H. pylori prevalence and high gastric cancer incidence country anda good candidate for a gastric cancer elimination program. The presence of an H. pylori infection is now considered as an indication for treatment of the infection. However, antimicrobial drug resistance is common among H. pylori in Koreamaking effective therapy problematic. Country-wide studies of the local and regionalantimicrobial resistance patterns are needed to choose the most appropriatetherapies. H. pylori and gastric cancer eradication can be both efficient andcost effective making it possible and practical to make Korea H. pylori and gastriccancer free. There is no reason to delay.
Abstract
Most gastric cancers are caused by infection with the common human bacterialpathogen, Helicobacter pylori. It is now accepted that gastric cancer can be preventedand virtually eliminated by H. pylori eradication and this knowledge wasresponsible for country-wide H. pylori eradication combined with secondary cancerprevention for those with residual risk that was introduced in Japan in 2013. Korea is a high H. pylori prevalence and high gastric cancer incidence country anda good candidate for a gastric cancer elimination program. The presence of an H. pylori infection is now considered as an indication for treatment of the infection. However, antimicrobial drug resistance is common among H. pylori in Koreamaking effective therapy problematic. Country-wide studies of the local and regionalantimicrobial resistance patterns are needed to choose the most appropriatetherapies. H. pylori and gastric cancer eradication can be both efficient andcost effective making it possible and practical to make Korea H. pylori and gastriccancer free. There is no reason to delay.
참고문헌 (32)
- Graham DY., "History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer", World J Gastroenterol, 20, pp.5191~5204 (2014)
- Comfort MW., "Gastric acidity before and after development of gastric cancer: its etiologic, diagnostic and prognostic significance", Ann Intern Med, 34, pp.1331~1348 (1951)
- Graham DY, "Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod", J Gastroenterol, 45, pp.1~8 (2010)
- Cheli R, "Gastritis : A Clinical Review" (1987), Springer-Verlag
- Correa P., "A human model of gastric carcinogenesis", Cancer Res, 48, pp.3554~3560 (1988)
- Shiotani A, "Eradication of gastric cancer is now both possible and practical", Semin Cancer Biol, 23(6 Pt B), pp.492~501 (2013)
- Warren JR, "Unidentified curved bacilli on gastric epithelium in active chronic gastritis", Lancet, 1, pp.1273~1275 (1983)
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 100B, Biologic Agents: A Review of Human Carcinogens, "International Agency for Research on Cancer", International Agency for Research on Cancer, 385~435 (2012)
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 61, Schistosomes, Liver Flukes and Helicobacter pylori, "International Agency for Research on Cancer", International Agency for Research on Cancer, ~ (1994)
- Helicobacter pylori Eradication as a Strategy for Preventing Gastric Cancer, "International Agency for Research on Cancer", International Agency for Research on Cancer, ~, pp.IARC Working Group Reports. Vol. 8 (2014)
- Asaka M, "Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan", J Gastroenterol, 49, pp.1~8 (2014)
- Asaka M., "A new approach for elimination of gastric cancer deaths in Japan", Int J Cancer, 132, pp.1272~1276 (2013)
- Graham DY, "The time to eradicate gastric cancer is now", Gut, 54, pp.735~738 (2005)
- Bracken MB., "Risk, Chance, and Causation: Investigating the Origins and Treatment of Disease" (2013), Yale University Press
- Hanada K, "Helicobacter pylori infection introduces DNA double-strand breaks in host cells", Infect Immun, 82, pp.4182~4189 (2014)
- Hanada K, "Helicobacter pylori and the molecular pathogenesis of intestinal-type gastric carcinoma", Expert Rev Anticancer Ther, 14, pp.947~954 (2014)
- Wang C, "Age, period, and cohort effects on gastric cancer mortality", Dig Dis Sci, 60, pp.514~523 (2015)
- Lim SH, "Prevalence and risk factors of Helicobacter pylori infection in Korea: nationwide multicenter study over 13 years", BMC Gastroenterol, 13, pp.104~ (2013)
- Rugge M, "OLGA staging for gastritis: a tutorial", Dig Liver Dis, 40, pp.650~658 (2008)
- Shin DW, "Preferences for the “screen and treat” strategy of Helicobacter pylori to prevent gastric cancer in healthy Korean populations", Helicobacter, 18, pp.262~269 (2013)
- Park JM, "The Korean perspective of Helicobacter pylori infection: lessons from the Japanese government’s policy to prevent gastric cancer", Dig Dis, 32, pp.290~294 (2014)
- Ohata H, "Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer", Int J Cancer, 109, pp.138~143 (2004)
- The Research Group for Population-based Cancer Registration in Japan, "Cancer incidence and incidence rates in Japan in 1986: estimates based on data from nine population-based cancer registries", Jpn J Clin Oncol, 21, pp.318~323 (1991)
- Chung JW, "The trends of oneweek first-line and second-line eradication therapy for Helicobacter pylori infection in Korea", Hepatogastroenterology, 58, pp.246~250 (2011)
- Yoon JH, "Trends in the eradication rates of Helicobacter pylori infection for eleven years", World J Gastroenterol, 18, pp.6628~6634 (2012)
- 정연수, "대구, 경북 지역의 Helicobacter pylori 제균 치료의 연도별 제균율 변화: 13년간의 다기관 연구", 대한소화기학회지, 63(2), pp.82~89 (2014), 대한소화기학회
- 전혜경, "Does Standard Triple Therapy Still Have a Role in First-Line Helicobacter pylori Eradication in Korea?", Journal of Korean Medical Science, 29(5), pp.619~620 (2014), 대한의학회
- 공은정, "Meta-Analysis of First-Line Triple Therapy for Helicobacter pylori Eradication in Korea: Is It Time to Change?", Journal of Korean Medical Science, 29(5), pp.704~713 (2014), 대한의학회
- Graham DY, "Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence", Clin Gastroenterol Hepatol, 12, pp.177.e3~186.e3 (2014)
- Wu JY, "Evidence-based recommendations for successful Helicobacter pylori treatment", Expert Rev Gastroenterol Hepatol, 8, pp.21~28 (2014)
- Furuta T, "Pharmacologic aspects of eradication therapy for Helicobacter pylori Infection", Gastroenterol Clin North Am, 39, pp.465~480 (2010)
- Lee SY., "Future candidates for indications of Helicobacter pylori eradication: do the indications need to be revised?", J Gastroenterol Hepatol, 27, pp.200~211 (2012)